Aclaris Therapeutics Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:$113M
Lead Investor(s):Jefferies LLC, Leerink Partners LLC

Estimated Revenue & Financials

  • Aclaris Therapeutics's estimated annual revenue is currently $7.4M per year.(?)
  • Aclaris Therapeutics received $86.3M in venture funding in August 2017.
  • Aclaris Therapeutics's estimated revenue per employee is $48,816
  • Aclaris Therapeutics's total funding is $113M.

Employee Data

  • Aclaris Therapeutics has 152 Employees.(?)
  • Aclaris Therapeutics grew their employee count by -3% last year.
  • Aclaris Therapeutics currently has 2 job openings.

Aclaris Therapeutics, Inc. is a dermatologist-led biopharmaceutical company committed to identifying, developing and commercializing innovative therapies to address significant unmet needs in dermatology, both medical and aesthetic, and immunology. Aclaris is focused on market segments with no FDA-approved medications or where treatment gaps exist. Aclaris was founded by dermatologists and is led by a team with extensive experience in developing and commercializing dermatologic treatments.